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Background:  Current  guidelines  place  emphasis  on the  determination  of  aortic  valve  area  (AVA)  for
deﬁning  an appropriate  treatment  strategy.  Invasive  and  non-invasive  modalities  are  used to  perform
planimetric  [transesophageal  echocardiography  (TEE)  and  cardiac  multidetector  computed  tomography
(MDCT)]  and  calculated  [catheter  examination  (CE),  transthoracic  echocardiography  (TTE)]  AVA  mea-
surements.
Purpose  and  methods:  We  investigated  100  patients  admitted  to evaluate  the  AVA  using  cardiac  MDCT
(CT),  TEE/TTE  as well  as  invasive  CE.
Results:  In  all  100  patients  we calculated  a  mean  AVA  of 0.79  ±  0.29  cm2 (female  50/100,  0.70  ±  0.19  cm2,
male  0.9  ±  0.21  cm2) determined  by all  investigated  examinations  (mean  ± SEM).  AVA  measure-
ments  determined  by  CT  were  signiﬁcantly  greater  (0.86  ±  0.25  cm2) than those  determined  by CE:
0.75  ± 0.18  cm2, p  = 0.01.  Echocardiographically  determined  AVA  was  comparable  to  CE (statistically  not
signiﬁcant).  Similar  results  were  seen  in all patients  regardless  of gender,  presence  of atrial  ﬁbrillation,
and  heart  rate.  We  calculated  a mean  AVA  for each  patient  and  evaluated  the  variance  of  the  AVA  deter-
mined  through  investigated  speciﬁc  examinations  as the bias.  Overall,  we  found  for  CT 0.13  ±  0.1  cm2,
CE  0.13 ± 0.11  cm2, TEE  0.16  ± 0.09  cm2, and  for TTE 0.16  ±  0.08  cm2 a speciﬁc  statistical  non-signiﬁcant
variance.  On  subgroups:  sinus  rhythm,  atrial  ﬁbrillation,  females,  males  or combination,  we  found  no
further  signiﬁcant  relevance  for the  speciﬁc  variance.
Conclusion:  Our  data  suggest  the  feasibility  of cardiac  MDCT  to  evaluate  the  correct  AVA regardless  of
rhythm,  heart  rate, and  sex.  The  planimetric  concept  to  determine  the AVA  with  CT  displaces  the  “gold-
standard”  CE  with  respect  to  elucidating  the  potencies  for complications,  i.e. cerebral  stroke.  Regardless  of
CT’s accessing  of  AVA  measurement  the  TTE  examination  should  remain  the  primary  method  of  screening
es.
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Calciﬁed aortic valve stenosis is the most frequently acquired
alvular disease in the western population [1]. Whereas symp-
omatic aortic valve stenosis is associated with a poor prognosis
2], the natural course of calciﬁed but nonstenotic aortic valves
hows high variability [3]. Valve replacement is the only treatment
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considerable for severe aortic valve stenosis [4,5]. Treatment deci-
sions regarding surgical versus percutaneous approaches of aortic
valve replacement are dependent upon patient comorbidities [4],
as well as on perioperative mortality risk e.g. as described by log
EuroScore [6]. Surgical valve replacement is the preferred option for
patients with a log EuroScore below 15% [5,7–10]. A new EuroScore
II was  launched at the 2011 meeting of the European Association for
Cardio-Thoracic Surgery in Lisbon to optimize peri-operative mor-
tality prediction [11,12] due to overestimation using the original
log EuroScore.
Guidelines clearly deﬁne the aortic valve area (AVA) as an
important parameter to guide the appropriate timing of valve
replacement besides clinical symptoms [13]. Evaluation of the
vier Ltd. All rights reserved.
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VA is achieved by invasive catheter examination (CE) of the
eft and the right heart pressures to determine the cardiac index
according to Fick’s equation) and calculate the AVA (according
o Gorlin equation), or by transthoracic echocardiography (TTE;
ccording to continuity equation), and by transesophageal echocar-
iography (TEE) of the AVA or by cardiac multidetector computed
omography (MDCT) allowing direct planimetry of the aortic
alve.
Currently, there is lack of data from large cohorts of patients with
evere aortic valve stenosis to allow direct comparisons of assessing
VA by different methods. Additionally, no study provides answers
n a large number of patients with aortic valve stenosis as to which
ode of evaluation is more favorable in patients with sinus rhythm
nd atrial ﬁbrillation.
In our study, the main focus was to describe retrospectively the
orrect AVA of 100 individuals with severe aortic valve stenosis
imply by evaluation of invasive and non-invasive measurements
f AVA. Furthermore, we aimed to evaluate the effect of rhythm
sinus or atrial ﬁbrillation) on the accuracy of the various modal-
ties. Third, we are describing assay-dependent bias issues of the
peciﬁc variance to detect the correct AVA (clinically determined
y using the mean of all examinations).
ethods
tudy design and methods
A total of 100 patients were enrolled in this study. Patients were
dmitted to the Division of Medicine, Department of Cardiology
Klinikum Bayreuth, Germany) due to severe aortic valve stenosis
ssessed externally through TTE. Each patient gave signed consent
or the anonymous collection of all clinical data.
ardiac MDCT
Each patient received beta-blocker (metoprolol succinate 95 mg
he night before and on the morning of the scan; Philips Bril-
iance 256 MDCT iCT; Philips, Amsterdam, the Netherlands) before
he examination (at noon) in order to reduce the heart rate to
0–60 beats per minute [14,15]. Just before scanning, nitroglyc-
rine 400 g was applied intravenously. Calcium scoring was
one natively using prospective gating on 65% RR interval and a
lice thickness of 2 mm.  Afterward, 80 ml  contrast medium was
nfused intravenously (iomeprol 350 ml)  and a tracking bolus sys-
em (Region of Interest in the aorta ascendens) was used to start
he scan (delay 8 s). Contrast enhanced scans were performed in
old inspiration to distinguish the cavum of the left ventricle from
he aortic valve and the great vessels (left ventricular outﬂow tract,
VOT, or ascending aorta). Cardiac helical protocol (spiral scan pro-
ocol) was used to establish retrospective data in 0.9 mm slice
hickness in order to create different reconstructions: 0%, 10%, 20%,
0%, 40%, 50%, 60%, 70%, 80%, and 90%. The batch from 0% to 90%
n a rate of 60 counts per minute (corresponding to a heart rate of
0 counts per minute) was established and focused on the aortic
alve. The speciﬁc AVA was individually determined by planimetry
setting the Region of Interest for Hounsﬁeld measurements) in the
0–30% RR interval scan (systole, in cm2) using the cusps as level
f measurement [14,16,17] (Fig. 1).
ransthoracic echocardiographyStandardized TTE (Philips iE33) was performed for each indi-
idual. We  used the continuity equation to determine the AVA for
ach patient. Diameter of the LVOT, gradient of the speciﬁc pres-
ure in the LVOT using pulsed wave Doppler function (pw Doppler)logy 63 (2014) 189–197
and continuous wave Doppler (cw Doppler) were assessed to deter-
mine the gradient of the pressure over the aortic valve to calculate
the AVA by continuity equation (in cm2) [18,19]. No further beta-
blockers were given prior to examination.
Transesophageal echocardiography
Patients were sedated and monitored accordingly for TEE
(Philips iE33). The echo probe was  positioned in the esophagus to
directly scan the aortic valve and to measure the AVA by planimetry
of the valve (in cm2) [20,21] (see Fig. 1). No further beta-blockers
were given prior to examination.
Catheter examination
All patients were transferred to the catheter laboratory (Siemens
Axiom Cath Lab, Munich, Germany) to examine the speciﬁc inva-
sive cardiac index (Fick’s equation), to determine the AVA (in
cm2) through Gorlin’s equation and through the mean gradient of
the pressure measured by retrograde probing of the left ventri-
cle across the aortic valve and by pulling back the pigtail catheter
(5F) [22–24]. Accordingly, the right heart CE was assessed with a
multipurpose catheter (MP, 6F) to determine cardiac index (Fick)
by sequentially pulling back the MP  catheter from the pulmonary
capillary wedge position to the right atrium. Blood gas analysis to
determine the speciﬁc oxygen saturation was  performed in the pul-
monary artery as well as in the right atrium simultaneously and
in the left ventricle. No further beta-blockers were given prior to
examination.
Statistical analysis
Data represent mean ± SEM as indicated. Relevant differences
between methods were assessed by pairwise comparison using
Student’s t-test. Repeated measures ANOVA variance test adjusted
to Bonferroni correction was used to assess individual differ-
ences between AVA using different methods. A p-value < 0.05 was
considered statistically signiﬁcant. Invasive CE was used as refer-
ence method (“gold standard”) for assessment of AVA. Correlation
between AVAs between different methods was  tested with the help
of the Pearson correlation test. All statistical tests were performed
with SPSS Statistics software, version 21.0 (IBM/SPSS, Inc., Chicago,
IL, USA).
Interobserver variability
To reduce bias by different observers known as inter-observer
variability, all AVA measurements were collected simultaneously
through three different observers and the mean AVA was used.
Completion of data collection
We  collected data of AVA from admitted patients with severely
calciﬁed and stenotic aortic valves as previously documented by
transthoracic echocardiography. For non-invasive cardiac MDCT,
we primarily collected complete data of AVA from 100 patients
(100%). A complete dataset was not achieved with CE (n = 99), TEE
(n = 74), or TTE (n = 68).
Reasons for missing data were: (I) TEE was performed in 100
patients but in only 74 subjects AVA could be deﬁned in respect of
scan artifacts due to severe calciﬁcations of the aortic valves. (II)
Data of AVA calculated through TTE were enrolled retrospectively
and no further opportunity was given to collect missing AVA prior
to valve replacement. (III) One patient refused invasive CE.
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Fig. 1. Examples for the planimetric evaluation of aortic valve area (AVA) by cardiac multidetector computed tomography (MDCT) (A) or transesophageal echocardiography
(B).  (A) Examples of two different scans to evaluate the AVA through cardiac MDCT. The right panel shows a scan of an 80-year-old female patient, sinus rhythm, 65 beats per
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can  in a patient with atrial ﬁbrillation. AVA was  measured 0.78 cm2.
esults
atient population
A total of 100 consecutive patients (mean age 79 ± 6 years) were
nonymously enrolled in this study and investigated by multiple
ethods to determine AVA. We  consecutively enrolled 50 female
atients (age 81 ± 6 years) and 50 male patients (age 78 ± 6 years). A
otal of 55 of the enrolled patients presented with sinus rhythm (age
8 ± 7 years): females n = 27, age 80 ± 7 years and males n = 28, age
6 ± 7 years. A total of 45 patients had atrial ﬁbrillation (age 81 ± 5
ears, females n = 23, age 82 ± 5 years and males n = 22, age 80 ± 5
ears). Two of the patients had a 2-chamber pace-maker secondary
o atrio-ventricular-block III◦ with sinus rhythm (data not shown)
see Table 1).
nvasive and non-invasive measurement of AVA: all patients
For all enrolled patients, we deﬁned the speciﬁc individual AVA
etermined by (I) non-invasive TTE, (II) TEE, (III) cardiac MDCT and
nvasive by CE. For the per-examination-analysis, we  collected the
ean AVA determined through the investigated examination for all
nrolled patients (n = 100). In contrast to other studies, we  primarilyeasured as 1.1 cm . The left panel shows a scan of a 65-year-old male patient, atrial
 RR interval. AVA was measured 0.64 cm2. (B) Transesophageal echocardiographic
enrolled patients with severe calciﬁed aortic valve stenosis to
assess the variability and application of non-invasive and invasive
evaluation methods of the AVA and additionally compared plani-
metric (TEE, CT) and calculated (TTE, CE) approaches to determine
the correct AVA.
Overall, we found an AVA of 0.79 ± 0.29 cm2 in all patients
(Fig. 2A). AVA measured by CT showed good correlation with the
gold standard CE (correlation coefﬁcient 0.69; p < 0.001). Using per-
examination-analysis (comparison of the different means of each
speciﬁc AVA determined through different methods), we demon-
strated a signiﬁcant difference in the determination of the speciﬁc
AVA using CT in comparison to CE. The AVA using CE evaluation
method was  signiﬁcantly smaller in comparison to the cardiac
MDCT (repeated measures ANOVA, mean difference 0.14, 95% con-
ﬁdence interval 0.02–0.25; p = 0.01). In comparison to CE, the AVA
measured with TTE or TEE was  comparable (no relevant statistical
difference between CE evaluated AVA and TTE or TTE).
For the per-patient-analysis, we  calculated a patient mean AVA
using all patient-dependent AVA values determined with the four
evaluation methods (CT, TTE, TEE, and CE). We deﬁned the speciﬁc
variance of a method by calculating the method-dependent differ-
ence of the AVA from the mean AVA for all individual patients as
previously described [14,17]. Further, we collected all variations
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Table  1
Demographic data. Patients were divided into groups with sinus rhythm (SR) or
atrial ﬁbrillation (AF). Demonstrated in the ﬁrst row is the mean age of the patient
population (all, SR, AF) ± standard error of the mean (SEM) (in years). The speciﬁc
number of patients subgrouped is indicated as n = xx and is given as females and
males. The average heart rate is demonstrated in the second row as mean ± SEM (in
beats per minute). No signiﬁcant differences between the subgroups were observed.
Age (years) Heart rate (beats
per minute)
All
All n = 100
Mean ±SEM 79 ± 6 60 ± 7
Female n = 50
Mean ±SEM 81 ± 6 61 ± 7
Male n = 50
Mean ±SEM 78 ± 6 60 ± 8
SR
All n = 55
Mean ±SEM 78 ± 7 60 ± 7
Female n = 27
Mean ±SEM 80 ± 7 60 ± 7
Male n = 28
Mean ±SEM 76 ± 7 61 ± 7
AF
All n = 45
Mean ±SEM 81 ± 5 58 ± 7
Female n = 23
Mean ±SEM 82 ± 5 61 ± 8
Male n = 22
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Fig. 2. Data for the analysis of the aortic valve area (AVA) (in cm2) for all patients. A
total of 100 patients with severe stenotic and calciﬁed aortic valves were included
in  this study. We  performed cardiac multidetector computed tomography (CT),
transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE)
as  well as an invasive catheterization (CE) to determine the AVA and assayed a per-
examination-analysis. The overall value of the AVA (mean ± SEM) determined in
all  examinations of 100 patients enrolled in this study was 0.79 ± 0.29 cm2. (A) We
determined a mean value of the AVA among all included patients following a sta-
tistical comparison (mean ± SEM [in cm2]): CT 0.86 ± 0.25 cm2, CE 0.76 ± 0.32 cm2,
TEE 0.75 ± 0.18 cm2, TTE 0.77 ± 0.19 cm2. The statistical analysis revealed a signiﬁ-
cant  difference between the determined mean AVA through CT in comparison to the
mean AVA determined through CE (shown as p = 0.01). Shown in the graph is the
median, 10th, 25th, and 90th percentile of the examination-speciﬁc determined
AVA. To determine a speciﬁc assay-dependent variance, we  created an individ-
ual patient-dependent mean AVA value as clinically done in regard to deﬁne the
individual therapeutic approach and we deﬁned the bias of the speciﬁc method by
calculating the patient-dependent differences of the speciﬁc assay to the mean AVA
(CT, CE, TEE, or TTE). Data of all these patients are shown in (B); bars are demonstrat-
were treated with beta-blockers to reduce heart rate or to reduceMean ±SEM 80 ± 5 63 ± 8
nd deﬁned the mean variation as the speciﬁc bias of an evaluation
ethod. No statistical signiﬁcance was observed among the differ-
nt methods in regard to the calculated variance to the determined
ean AVA (Fig. 2B).
nvasive and non-invasive measurement of AVA: subgroup
nalysis
We  divided the total population into two subgroups among
he gender dependent comparison of male and female patients.
n male patients, n = 50 (Fig.  3A and B), we observed comparable
VAs for TTE or TEE in comparison to CE but signiﬁcant differences
p = 0.001) between CT-evaluated AVA (0.94 ± 0.23 cm2) and CE
0.92 ± 0.38 cm2). There was no statistical difference in the deter-
ined AVA and there was no statistical bias of any method (CT, CE,
EE, or TTE).
In female patients, n = 50 (Fig. 4A and B), again we  observed
omparable aortic valve areas for TTE or TEE in comparison to
E but signiﬁcant differences (p = 0.03) between CT-evaluated AVA
0.77 ± 0.25 cm2) and CE (0.62 ± 0.21 cm2). No other statistical sig-
iﬁcance could be determined in this comparison.
Heart rhythm is well documented to affect cardiac MDCT evalu-
tion and assessing AVA in poorly controlled heart rhythm with
ardiac MDCT, great statistical signiﬁcant variations would be
ssumed.
Patients in sinus rhythm (n = 55) showed again a statistical sig-
iﬁcant difference (p = 0.01) between the AVA determined through
T (0.91 ± 0.30 cm2) and CE (0.83 ± 0.38 cm2). Our data showed no
urther signiﬁcant differences among the non-invasive echocardio-
raphical assessed AVA: TTE or TTE in comparison to CE (Fig. 5A).
Of note, patients with atrial ﬁbrillation showed the same sta-
istical difference in regard to the evaluation of AVA with CT to CE
Fig. 6A) (p = 0.02).With regards to the examination speciﬁc variation (speciﬁc bias)
either subgroups in sinus rhythm nor in atrial ﬁbrillation statisti-
al signiﬁcant alterations were observed (Figs. 5B and 6B).ing  the variance (mean), error bars show the SEM (both in cm2), the absolute data
(mean ± SEM) are shown below the labels: CT 0.13 ± 0.1 cm2, CE 0.13 ± 0.11 cm2,
TEE  0.16 ± 0.09 cm2, TTE 0.16 ± 0.08 cm2. No statistical difference was observed.
Atrial ﬁbrillation is characterized by irregular ﬁlling of the left
ventricle in diastole leading to relevant problems in cardiac CT scan-
ning for coronary arteries. To solve this problem, step and shoot
scanning, iterative prospective reconstructions and single (“one”)
cardiac cycle scanning procedures were developed. In contrast,
evaluation of AVA is dependent on the systole. Thus, all scans were
performed in cardiac helical process to acquire all cardiac cycles:
diastole and systole. A scan protocol preceding cardiac cycles above
800 ms  favored diastole scanning and was not assessed. All patientsheart rate to 50–60 bpm even when atrial ﬁbrillation occurred.
Best scanning condition for the determination of the AVA were
achieved with sinus rhythm and a heart rate below 65 beats per
T. Anger et al. / Journal of Cardiology 63 (2014) 189–197 193
Fig. 3. Data for the analysis of the aortic valve area (AVA) (in cm2) for male
patients. Fifty male patients were included. The speciﬁc analyses (non-/invasive)
demonstrated different AVA values. The overall value of the AVA (mean ± SEM)
determined in all examinations of 50 male patients enrolled in this study was
0.9  ± 0.21 cm2. (A) We  determined a mean value of the AVA among all included
male patients following a statistical comparison (mean ± SEM [in cm2]): multi-
detector computed tomography (CT) 0.94 ± 0.23 cm2, catheter examination (CE)
0.92 ± 0.38 cm2, transesophageal echocardiography (TEE) 0.79 ± 0.16 cm2, transtho-
racic echocardiography (TTE) 0.83 ± 0.18 cm2. The statistical analysis revealed a
signiﬁcant difference between the determined mean AVA through CT in comparison
to  the mean AVA determined through CE (shown as p = 0.001). Shown in the graph
is the median, 10th, 25th, and 90th percentile of the examination-speciﬁc deter-
mined AVA. (B) Bars demonstrate the variance (mean), error bars of the SEM (both in
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Fig. 4. Data for the analysis of the aortic valve area (AVA) (in cm2) for female
patients. Fifty female patients were included. The speciﬁc analyses (non-/invasive)
demonstrated different AVA values. The overall value of the AVA (mean ± SEM)
determined in all examinations of 50 female patients enrolled in this study was
0.7  ± 0.19 cm2. (A) We determined a mean value of the AVA among all included
female patients following a statistical comparison (mean ± SEM [in cm2]): multi-
detector computed tomography (CT) 0.77 ± 0.25 cm2, catheter examination (CE)
0.62 ± 0.21 cm2, transesophageal echocardiography (TEE) 0.1 ± 0.19 cm2, transtho-
racic echocardiography (TTE) 0.70 ± 0.18 cm2. Statistical signiﬁcance among the
different methods was observed for CT and CE indicating signiﬁcantly smaller AVA
values determined with CE in comparison to CT in female patients (shown as
p  = 0.03). Shown in the graph is the median, 10th, 25th, and 90th percentiles of the
examination-speciﬁc determined AVA. (B) Bars demonstrate the variance (mean),
2m2), the absolute data (mean ± SEM) are shown below the labels: CT 0.12 ± 0.1 cm2,
E 0.14 ± 0.12 cm2, TEE 0.19 ± 0.1 cm2, TTE 0.17 ± 0.08 cm2. No statistical difference
as  observed.
inute [14]. Even in this small subgroup (n = 18) there was  a sta-
istically signiﬁcant difference between CT and CE with no further
ifferences among the non-invasive echocardiographic techniques
EE or TTE (Fig. 7A and B).
nvasive and non-invasive measurement of AVA:
ariance-analysis
In order to deﬁne a method-speciﬁc bias we  performed a
er-patient-analysis. Therefore, a mean AVA calculated from all
etermined AVA values (with CT, CE, TEE, and TTE) for each indi-
idual patient was used as baseline to deﬁne the variance of each
sed method. These variances were summarized and compared
o deﬁne the examination-dependent bias for the measurement
f AVA. Interestingly, we could not discover any statistically
igniﬁcant bias for any speciﬁc examination observed in this patient
opulation with severe calciﬁed and stenotic aortic valves (see allerrors bars of the SEM (both in cm ), the absolute data (mean ± SEM) are shown
below the labels: CT 0.14 ± 0.11 cm2, CE 0.12 ± 0.09 cm2, TEE 0.15 ± 0.08 cm2, TTE
0.16  ± 0.09 cm2. No statistical difference was observed.
ﬁgures, part B: no statistical signiﬁcance could be observed in any
calculation). However, when calculating the difference between
the AVA for each speciﬁc method, the mean calculated AVA per
patient was used as the speciﬁc variance using repeated measures
of ANOVA variance test with Bonferroni correction.
Discussion
Study designWe evaluated 100 patients with previously documented
(through TTE) severe aortic valve stenosis to describe
method-speciﬁc characteristics. While other studies used pri-
marily unsuspected volunteers with less severe aortic valve
194 T. Anger et al. / Journal of Cardiology 63 (2014) 189–197
Fig. 5. Data for the analysis of the aortic valve area (AVA) (in cm2) for patients in
sinus rhythm (SR). A total of 55 patients in SR were included: females n = 27, males
n  = 28. The speciﬁc analyses (non-/invasive) demonstrate different AVA values. The
overall value of the AVA (mean ± SEM) determined in all examinations of 55 patients
in  SR enrolled in this study was  0.84 ± 0.23 cm2. (A) We  determined a mean value
of  the AVA among all included patients in SR following a statistical comparison
(mean ± SEM [in cm2]): multidetector computed tomography (CT) 0.91 ± 0.30 cm2,
catheter examination (CE) 0.83 ± 0.38 cm2, transesophageal echocardiography (TEE)
0.75 ± 0.15 cm2, transthoracic echocardiography (TTE) 0.82 ± 0.20 cm2. The sta-
tistical analysis revealed a signiﬁcant difference between the determined mean
AVA with CT in comparison to the mean AVA determined with CE (shown as
p  = 0.01). Shown in the graph is the median, 10th, 25th, and 90th percentiles of the
examination-speciﬁc determined AVA. (B) Bars demonstrate the variance (mean),
errors bars the SEM (both in cm2), the absolute data (mean ± SEM) are shown
below the labels: CT 0.14 ± 0.12 cm2, CE 0.15 ± 0.13 cm2, TEE 0.19 ± 0.12 cm2, TTE
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Fig. 6. Data for the analysis of the aortic valve area (AVA) (in cm2) for patients in
atrial ﬁbrillation (AF). A total of 45 patients in AF were included: females n = 23, males
n  = 22. The speciﬁc analyses (non-/invasive) are demonstrating different AVA values.
The  overall value of the AVA (mean ± SEM) determined in all examinations of 45
patients in AF enrolled in this study was 0.74 ± 0.19 cm2. (A) We determined a mean
value of the AVA among all included patients in AF following a statistical comparison
(mean ± SEM; in cm2): multidetector computed tomography (CT) 0.78 ± 0.19 cm2,
catheter examination (CE) 0.69 ± 0.24 cm2, transesophageal echocardiography (TEE)
0.76 ± 0.21 cm2, transthoracic echocardiography (TTE) 0.71 ± 0.17 cm2. The statisti-
cal  analysis revealed a signiﬁcant difference between the determined mean AVA
through CT in comparison to the mean AVA determined through CE (shown as
p  = 0.02). Shown in the graph is the median, 10th, 25th, and 90th percentiles of the
examination-speciﬁc determined AVA. (B) Bars demonstrate the variance (mean),
errors bars the SEM (both in cm2), the absolute data (mean ± SEM) are shown
below the labels: CT 0.13 ± 0.09 cm2, CE 0.12 ± 0.07 cm2, TEE 0.16 ± 0.06 cm2, TTE
scan quality: best cardiac CT scan quality was  achieved at heart.18 ± 0.1 cm2. No statistical difference was observed.
tenosis, we exclusively enrolled patients with severe calciﬁed
nd stenotic aortic valves to deﬁne speciﬁc method characteristics
nd to describe a stepwise diagnostic approach. Clinically, the
nvestigated methods were used to describe individual patient
haracteristics in order to deﬁne best individual therapeutic
pproach: surgical aortic valve replacement or transcatheter aortic
alve implantation (TAVI). From the 100 evaluated patients, 50
atients underwent transfemoral aortic valve implantation using
elf-expanding Nitinol based aortic CoreValve® stent prosthesis
ystem (Medtronic, Minneapolis, MN,  USA). The non-invasive
ardiac MDCT scans were used as the method to evaluate the
ortic annulus, aortic root, distance of aortic annulus to the
oronary ostia, and further details for the implantation procedure
ith respect to implantation procedure guidelines [25,26]. TEE0.14  ± 0.06 cm2. No statistical difference was observed.
examination was  performed in order to evaluate the size of the
aortic annulus and the original AVA. TEE is often used as helpful
assistance while TAVI procedure is performed [27]. The invasive CE
approach was  applied to evaluate existence and extent of coronary
artery disease.
Inﬂuence of beta-blockers in determination of AVA
Beta-blockers were given exclusively 30 min  prior to cardiac CT
examination to reduce heart rate in order to optimize individualrates between 50 and 60 beats per minute [14,15,28]. Prior to TTE
(AVA determined by continuity equation) or CE (AVA determined
by Gorlin’s equation) no beta-blockers were given additionally. By
T. Anger et al. / Journal of Cardio
Fig. 7. Data for the analysis of the aortic valve area (AVA) (in cm2) for patients
in sinus rhythm with heart rate below 65/min. A total of 34 patients in sinus
rhythm and with a heart rate in rest below 65 beats per minute (best conditions)
were included: females n = 16, males n = 18. The speciﬁc analyses (non-/invasive)
demonstrate different AVA values. The overall value of the AVA (mean ± SEM)
determined in all examinations of 34 patients in best conditions enrolled in
this  study was  0.84 ± 0.18 cm2. (A) We determined a mean value of the AVA
among all included patients in best conditions following a statistical comparison
(mean ± SEM [in cm2]): multidetector computed tomography (CT) 0.88 ± 0.23 cm2,
catheter examination (CE) 0.84 ± 0.34 cm2, transesophageal echocardiography (TEE)
0.80 ± 0.15 cm2, transthoracic echocardiography (TTE) 0.85 ± 0.19 cm2. The statisti-
cal analysis revealed a signiﬁcant difference between the determined mean AVA
through CT in comparison to the mean AVA determined through CE (shown as
p  = 0.03). Shown in the graph is the median, 10th, 25th, and 90th percentiles of the
examination-speciﬁc determined AVA. (B) Bars demonstrate the variance (mean),
errors bars of the SEM (both in cm2), the absolute data (mean ± SEM) are shown
b
0
m
v
t
T
a
t
v
P
m
a
m
assess normal scan quality either in sinus rhythm (or atrial ﬁbrilla-elow the labels: CT 0.13 ± 0.12 cm2, CE 0.18 ± 0.13 cm2, TEE 0.20 ± 0.13 cm2, TTE
.19  ± 0.09 m2. No statistical difference was observed.
eans of cardiac CT, AVA can be described by planimetry of the
alve itself independent of heart rate or left ventricular contrac-
ility [29]. Beta-blockers could reduce left ventricular contractility.
his would decrease pressure gradient throughout the aortic valve
nd ﬁnally lead to smaller gradients in TTE or in cardiac catheteriza-
ion (Gorlin’s equation using “mean gradient throughout the aortic
alve”).
lanimetric or calculated approach to assess AVA
Clinicians were confronted whether more non- or invasive
ethods are used to deﬁne clearly the correct AVA due to best ther-
peutic approach for the individual patient. Both, non- and invasive
ethods are calculated and planimetric approaches.logy 63 (2014) 189–197 195
Calculated AVA (TTE, CE)
There is currently a controversial discussion between accuracy
of TTE-based equation or invasive catheter-based calculation of the
AVA [30]. Overall, there seems to be a good correlation between the
two methods with regard to the blood ﬂow relations through the
valve [22,23] and the left ventricular function [19,31]. Dobutamine
stress echocardiography [2] is used to deﬁne aortic valve stenosis
with low gradient [32,33].
The invasive catheter-based evaluation using Fick/Gorlin equa-
tion [24,30] has been the gold standard in interventional
cardiologists’ hands especially in order to preoperatively evalu-
ate the status of the coronary arteries. However, many limitations
result in incorrect evaluation of the stenosis severity: i.e. assumed
patient-dependent oxygen absorption, mean gradient of the aortic
valve irrespective of the left ventricular function [34], and irrespec-
tive of the size of the left ventricular cavum [35,36].
Planimetric AVA (TEE, cardiac MDCT)
In contrast, the direct planimetric approach using TEE or non-
invasive cardiac MDCT is a better deﬁned measurement of the AVA
without any further calculation. The exception is clearly the extent
of calciﬁcations on the cusps of the aortic valve which results in
underestimation of the AVA using TEE in comparison to cardiac
MDCT [21,37]. While cardiac MDCT tends to overestimate AVA
[38], TEE is unable to deﬁne the AVA in about one third of patients
[20,21,39]. Clearly, non-invasive cardiac MDCT shows advantages
over invasive CE: the invasive procedure primarily calculates the
AVA and is associated with procedure-related complications i.e.
realistic stroke [40].
Signiﬁcance of cardiac MDCT on determination of AVA
In a meta-analysis, signiﬁcant correlations between AVA deter-
mined through cardiac MDCT or TTE were observed [17]. While
the direct planimetric determination of the AVA is observer-
dependent, evaluation of AVA through aortic valve cusps is
commonly recommended [14]. Using LVOT measurement in car-
diac MDCT to adjust and calibrate continuity equation of TTE, the
AVA determination correlates the best between cardiac MDCT and
TTE [31]. Beside the evaluation of the AVA, cardiac MDCT exam-
ination offers (I) status of the coronary artery disease [41] and
(II) usefulness for planning TAVI to characterize anatomical back-
ground of ascending aorta, aortic valve annulus, and aortic valve
root [14,42,43]. The impact of the quantity of aortic valve calciﬁ-
cations on the AVA measurement is negotiable in cardiac MDCT in
contrast to TEE [21].
Inﬂuence of cardiac rhythm on AVA evaluation
To date no other study has focused on the input of rhythm on
the characterization of AVA. Both, sinus rhythm or atrial ﬁbrilla-
tion are well known to inﬂuence cardiac MDCT imaging quality.
While sinus rhythm leads to normal scan quality, patients suf-
fering atrial ﬁbrillation are not appropriate candidates for cardiac
MDCT due to unequal diastolic ﬁlling in atrial ﬁbrillation leading to
severe scanning artifacts using cardiac helical scanning procedure
to characterize AVA (in systole) [14,41–43].
In our hands, for the ﬁrst time, a direct comparison of AVA
quality was performed showing no difference between AVA data
collected in sinus rhythm or in atrial ﬁbrillation.
The inﬂuence of the heart rate while scanning is known as an
important parameter for scan quality. Heart rate below 65/min willtion) [14]. In our hands, the best scan quality of cardiac MDCT was
observed with heart rate below 65/min and sinus rhythm [44]. Even
under deﬁned “best conditions” (see above), no further statistical
1  Cardio
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ifference between planimetric CT or calculated CE approaches to
etermine AVA were observed in 34 patients suffering severe aortic
alve stenosis with AVA below 0.8 ± 0.3 cm2 (mean ± SEM).
VA in CT in comparison to CE
Comparing AVA determined through CT with the gold standard
E, we measured statistically relevant higher AVA in the CT group.
easurement of AVA by CT uses direct planimetric determination
ithout any limitations. It is known that TTE underestimates the
VA [14]. TTE underestimates the area of the LVOT [14] leading to
aulty calculations of the AVA [45]. Similarly, TEE lacks accuracy
f AVA measurement due to valve sclerosis on the cusp and the
mpossibility to determine the correct AVA by planimetry [20,21].
he invasive CE is considered as gold standard to explore correct
VA [23]. We  found several outlier patients, leading to higher AVA
ssessed by MDCT compared to TTE, TE, or CE. With respect to the
resent study, we think that CT is a helpful and valid measurement
f AVA with respect to the non-invasive planimetric character of
he method. Further validation of correct assessment of AVA in this
articular group of patients with severe calciﬁed aortic stenosis is
eeded to determine the optimal method.
onclusion
Characterizing 100 patients (TTE, TEE, CE, and cardiac MDCT)
ith severe aortic valve stenosis, we directly compared invasive
nd non-invasive methods to evaluate the correct AVA. All methods
n the hands of experienced observers achieved correct evalua-
ions of the AVA valid for clinical practice. AVA measured by MDCT
orrelated well with AVA assessed by CE. It appears that a staged
pproach with regard to the evaluation of the AVA is feasible: non-
nvasive cardiac MDCT could serve as an initial evaluation tool and
f there is a concern about the status of coronary arteries, invasive
atheter coronary angiography examinations should be performed,
n particular when the coronary status remains unclear after MDCT
valuation. As a screening method for severe aortic valve stenosis,
se of TTE is established. However, TEE has only limited value for
creening of AVA in particular in calciﬁed aortic stenosis but has a
ole during TAVI procedures. Cardiac MDCT provides most details
or clinical practice and when the heart rate is below 65/min and
n sinus rhythm indicating improved scan quality. Cardiac MDCT is
he most helpful tool to characterize the planimetric AVA, as well as
he coronary artery status [33,44]. In individual comparisons MDCT
ended to produce higher measures of AVA compared to TTE/TEE
nd the gold-standard CE in the present study. Further validation of
orrect assessment of AVA and identiﬁcation of individual factors
nﬂuencing differences in AVA assessment in this particular group
f patients with severe calciﬁed aortic stenosis is needed.
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